This article was written by Follow With a background as a RN, I analyze healthcare-related stocks by evaluating clinical data, treatment guidelines, and market...
2025 trading behavior prominently featured momentum. Certain categories of stocks soared to new heights while others were left in the dust. Toward the end...
Studies have shown that a large percentage of employees often automatically choose low-deductible health insurance plan options that ultimately cost them more. Another study...
After a steep decline in August, the latest Korean export data indicates that things are headed in the right direction. Crucially for Korea’s tech-heavy...
Originally posted on October 7, 2023 In this weekly market report, we look at the various asset classes, sectors, equity categories, and exchange-traded funds...
What’s the best-performing sector in 2023? You might say something tech-related. While that is true among large-cap US equities, small and mid-sized companies within...
At a Glance In light of Lyra Therapeutics’ (NASDAQ:LYRA) recent financial and clinical data, investors face a complex investment landscape. On the clinical side,...